Tech Focus Guyana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Guyana.

Press releases published on September 2, 2026

4 minutes ago

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026

Indeterminate GlobeNewswire

4 minutes ago

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 août 2026

Indeterminate GlobeNewswire

9 minutes ago

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

26 minutes ago

Patton and alfanar Partner™ to Accelerate Secure Digital Transformation of Saudi Power Infrastructure

Indeterminate GlobeNewswire

32 minutes ago

BioRestorative Therapies Announces Reverse Stock Split

Indeterminate GlobeNewswire

an hour ago

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Zoom Appoints Former Oracle CFO Jeff Epstein to Board of Directors; Jonathan Chadwick to Retire

Indeterminate GlobeNewswire

1 hours ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

1 hours ago

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

1 hours ago

Byrna Appoints Matt McBrady to Board of Directors

Indeterminate GlobeNewswire

1 hours ago

Supernus Pharmaceuticals to Participate in September Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

Indeterminate GlobeNewswire

2 hours ago

Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

Indeterminate GlobeNewswire

2 hours ago

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

Indeterminate GlobeNewswire

2 hours ago

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

nCino to Participate in Upcoming Investor Event 

Indeterminate GlobeNewswire

2 hours ago

Surrozen to Present at Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

Kyverna Therapeutics to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

Shattuck Labs Announces Participation in Upcoming September Investor Conferences

Indeterminate GlobeNewswire